
Guest Blog–How Collaboration is Advancing Research and Clinical Care in Pediatric Cancer
By Guest Blogger Dr. Lynne Davies, Operations Manager, International Cancer Research Program It is with great excitement that I write to let you know
By Guest Blogger Dr. Lynne Davies, Operations Manager, International Cancer Research Program It is with great excitement that I write to let you know
[vc_row][vc_column][vc_single_image image=”11180″ img_size=”full”][vc_column_text] By CAC2 Member Patti Gustafson, Swifty Foundation For years we looked to medical professionals to tell us what we needed to know
By Guest Blogger Hilary Woo, Dietetic Intern, Texas Woman’s University Fighting with food has been a motto that I’ve had ever since deciding to pursue
[vc_row][vc_column][vc_column_text] By CAC2 Member Carolyn Breinich In 2019, I attended my first CAC2 Summit in Columbus, Ohio. It was there where Mariah, a 40-year survivor,
[vc_row][vc_column][vc_column_text] By CAC2 Member Joe Baber If the Creating Hope Act (S. 4010) does not pass the Senate by December 11, THIS YEAR we will lose the best tool
[vc_row][vc_column][vc_column_text] By CAC2 Member Bob Piniewski, People Against Childhood Cancer [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Childhood cancer statistics, like all statistics (1), can be confusing. Any statistic can be used
[vc_row][vc_column][vc_column_text]By Guest Blogger Sarah Milberg, Co-Chair of the Alliance for Childhood Cancer and Director of Government Relations and Advocacy for the St. Baldrick’s Foundation Today is
[vc_row][vc_column][vc_column_text]By Guest Blogger Sarah Milberg, Co-Chair of the Alliance for Childhood Cancer and Director of Government Relations and Advocacy for the St. Baldrick’s Foundation For
[vc_row][vc_column][vc_column_text] By CAC2 Member Mariah Forster Olson, Neuroblastoma Children’s Cancer Society [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]As a long-term childhood cancer survivor with numerous late effects, I have had 39
[vc_row][vc_column][vc_column_text] By CAC2 Member Cesare Spadoni (aPODD). [/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]“Pharma and biotech companies do not develop drugs for kids with cancer!” How many times have we